INGN Inogen Inc

Price (delayed)

$8.15

Market cap

$192.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.15

Enterprise value

$106.82M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The debt has declined by 2.8% year-on-year
Inogen's gross profit has decreased by 13% YoY but it has increased by 2.9% from the previous quarter
Inogen's net income has decreased by 8% YoY but it has increased by 6% from the previous quarter
The quick ratio has contracted by 40% YoY and by 8% from the previous quarter
The equity has declined by 32% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
23.58M
Market cap
$192.15M
Enterprise value
$106.82M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.33
Earnings
Revenue
$321.52M
EBIT
-$96.92M
EBITDA
-$77.59M
Free cash flow
-$26.01M
Per share
EPS
-$4.15
Free cash flow per share
-$1.11
Book value per share
$8.23
Revenue per share
$13.74
TBVPS
$11.66
Balance sheet
Total assets
$315.6M
Total liabilities
$123.7M
Debt
$22.11M
Equity
$191.9M
Working capital
$125.28M
Liquidity
Debt to equity
0.12
Current ratio
2.7
Quick ratio
2.17
Net debt/EBITDA
1.1
Margins
EBITDA margin
-24.1%
Gross margin
40.5%
Net margin
-30.1%
Operating margin
-32.3%
Efficiency
Return on assets
-28.4%
Return on equity
-42.9%
Return on invested capital
-78.6%
Return on capital employed
-40.1%
Return on sales
-30.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
3.69%
1 week
11.8%
1 month
-5.34%
1 year
-28.57%
YTD
48.45%
QTD
0.99%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$321.52M
Gross profit
$130.34M
Operating income
-$103.75M
Net income
-$96.68M
Gross margin
40.5%
Net margin
-30.1%
The operating margin has contracted by 27% YoY but it has grown by 7% from the previous quarter
The net margin has declined by 23% year-on-year but it has grown by 7% since the previous quarter
Inogen's gross profit has decreased by 13% YoY but it has increased by 2.9% from the previous quarter
The revenue has declined by 13% year-on-year

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.99
P/S
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.33
Inogen's EPS has increased by 6% from the previous quarter but it has decreased by 6% YoY
INGN's P/B is 55% below its 5-year quarterly average of 2.2 but 24% above its last 4 quarters average of 0.8
The equity has declined by 32% year-on-year and by 6% since the previous quarter
The stock's price to sales (P/S) is 73% less than its 5-year quarterly average of 2.2 but 18% more than its last 4 quarters average of 0.5
The revenue has declined by 13% year-on-year

Efficiency

How efficient is Inogen business performance
Inogen's return on equity has shrunk by 53% YoY and by 3.9% QoQ
Inogen's ROA has decreased by 37% YoY
Inogen's ROS has decreased by 24% YoY but it has increased by 7% from the previous quarter
INGN's ROIC is down by 20% YoY

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is 155% greater than its total liabilities
The quick ratio has contracted by 40% YoY and by 8% from the previous quarter
The company's current ratio fell by 40% YoY and by 6% QoQ
The debt is 88% smaller than the equity
The debt to equity has soared by 50% YoY and by 9% from the previous quarter
The equity has declined by 32% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.